These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9293035)

  • 1. Polymeric controlled delivery for immunization.
    Kuntz RM; Saltzman WM
    Trends Biotechnol; 1997 Sep; 15(9):364-9. PubMed ID: 9293035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization: a realistic alternative.
    Otczyk DC; Cripps AW
    Hum Vaccin; 2010 Dec; 6(12):978-1006. PubMed ID: 21150284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery.
    Mishra N; Singh D; Sharma S; Baldi A
    Curr Drug Deliv; 2014; 11(6):729-43. PubMed ID: 25007830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mucosal immunity through systemic immunization: Phantom or reality?
    Su F; Patel GB; Hu S; Chen W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1070-9. PubMed ID: 26752023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology solutions for mucosal immunization.
    Chadwick S; Kriegel C; Amiji M
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
    Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems.
    Aguado MT
    Vaccine; 1993; 11(5):596-7. PubMed ID: 8488720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in mucosal vaccine development.
    Chen H
    J Control Release; 2000 Jul; 67(2-3):117-28. PubMed ID: 10825547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes.
    Sherwood JK; Zeitlin L; Whaley KJ; Cone RA; Saltzman M
    Nat Biotechnol; 1996 Apr; 14(4):468-71. PubMed ID: 9630921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal delivery of vaccines in domestic animals.
    Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA
    Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting mucosal surfaces for the development of mucosal vaccines.
    Meeusen EN
    Vaccine; 2011 Nov; 29(47):8506-11. PubMed ID: 21945494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female genital tract immunity: distinct immunological challenges for vaccine development.
    Naz RK
    J Reprod Immunol; 2012 Jan; 93(1):1-8. PubMed ID: 22154945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases.
    Lin CY; Lin SJ; Yang YC; Wang DY; Cheng HF; Yeh MK
    Hum Vaccin Immunother; 2015; 11(3):650-6. PubMed ID: 25839217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances on biodegradable polymeric carrier-based mucosal immunization: an overview.
    Kaur L; Sharma A; Yadav AK; Mishra N
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):452-464. PubMed ID: 28685588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to pediatric vaccine delivery.
    O'Hagan DT; Rappuoli R
    Adv Drug Deliv Rev; 2006 Apr; 58(1):29-51. PubMed ID: 16480788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.
    Czerkinsky C; Holmgren J
    Curr Top Microbiol Immunol; 2012; 354():1-18. PubMed ID: 21053117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
    Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
    Sharma R; Agrawal U; Mody N; Vyas SP
    Biotechnol Adv; 2015; 33(1):64-79. PubMed ID: 25499178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.